Facioscapulohumeral muscular dystrophy type 2
Clinical trials for Facioscapulohumeral muscular dystrophy type 2 explained in plain language.
Never miss a new study
Get alerted when new Facioscapulohumeral muscular dystrophy type 2 trials appear
Sign up with your email to follow new studies for Facioscapulohumeral muscular dystrophy type 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could umbilical cord stem cells ease muscle weakness in FSHD?
Symptom relief Recruiting nowThis early-stage study tests whether stem cells from umbilical cord lining can safely help people with FSHD, a genetic muscle-weakening disease. Sixteen adults will receive two doses of the cells and two doses of a placebo (saline) through an IV, in random order. The main goal is…
Matched conditions: FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY TYPE 2
Phase 1 • Sponsor: Restem, LLC. • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can blood markers predict the course of a rare muscle disease?
Knowledge-focused Recruiting nowThis study follows 50 adults with facioscapulohumeral muscular dystrophy type 2 (FSHD2), a rare inherited muscle disease, for 18 months. Researchers will measure muscle function and severity using standard clinical tests and collect blood samples to look for markers that might pr…
Matched conditions: FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY TYPE 2
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC